SpaceX Targets Nearly 2 Trillion Valuation in IPO Betting on Musks RocketstoAI Vision China Calls for APEC Cooperation as Commerce Minister Skips Opening Over Urgent Official Business China Investors Rush to Exit Amid Crackdown on Illicit CrossBorder Stock Trading Salesforce CRM Expands Agent Fabric to Serve as MultiVendor AI Control Plane Verisk Analytics Outlook Wall Street Sentiment and Analyst Perspective Goldman Sachs Russias Crude Exports Remain Stable Despite Latest US Sanctions CART Q1 2026 Earnings EPS Misses Estimates Despite Strong Operational Execution Kiniksa Pharmaceuticals KNSA Q1 2026 Earnings EPS Surprises to the Upside as Stock Dips KNTK Q1 2026 Earnings EPS Misses Estimates Amid Challenging Market Conditions BSM Q1 2026 Earnings Massive EPS Miss Amidst 8586 Surprise Downside COLB Q1 2026 Earnings Earnings Beat Driven by Strong Net Interest Income Shares Decline on Macro Concerns AAOI Q1 2026 Earnings EPS Misses Estimates as Investors Focus on LongTerm Strategy Rexford Industrial Realty REXR Edges Higher as Key Support Levels Hold Amid Consolidation Unifi Inc UFI Edges Higher as Stock Tests Key Support Level Near 392 Natera Inc NTRA Holds Above Support as Shares Gain 156 Uxin Limited UXIN Faces Resistance at 226 as Shares Slip 227 NuCana NCNA Rallies 75 as Stock Climbs Above Key Support Level ABB India Call Option and Delhivery Put Option Options Market Analysis SELLAS Life Sciences Group SLS Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Focuses on Pipeline Progress Real Messenger Warrants RMSGW Hover at Penny Level Amidst Flat Trading Duluth Holdings DLTH Q1 2026 Earnings EPS Surprises to the Upside Yet Stock Declines CBLL Q1 2026 Earnings EPS Misses Estimates Revenue Data Unavailable Stock Edges Lower TGEN Q1 2026 Earnings EPS Surprises to the Upside Stock Rises 79 FFIN Q1 2026 Earnings EPS Beat Surprise of 38 Drives Positive Stock Movement CC Q1 2026 Earnings Chemours Surpasses Estimates with Strong EPS Surprise Traws Pharma Inc TRAW Q1 2026 Earnings Narrower Net Loss Beats Estimates as Clinical Pipeline Advances ARM Q1 2026 Earnings EPS Beat Fails to Lift Shares as Market Weighs Headwinds